Synthesis and antimycobacterial activity of substituted 2-nitro-1-(4-tolylsulfonyl)-2-(3-methylphenyl-1,2,4-oxadiazol-5-yl)ethanes

Pharmaceutical Chemistry Journal

Volumn 40, Issue 7, 2006, Pages 377-379

  Tyrkov, A G ^a   Urlyapova, N G ^b   Daudova, A D ^b  

^a ASTRAKHAN STATE UNIVERSITY   (Russian Federation)

^b Leprosy Research Institute   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

2 NITRO 1 (4 TOLYLSULFONYL) 2 (3 METHYLPHENYL 1,2,4 OXADIAZOL 5 YL)ETHANE DERIVATIVE; ANTIMYCOBACTERIAL AGENT; DAPSONE; ISONIAZID; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANTIBACTERIAL ACTIVITY; ANTIMYCOBACTERIAL ACTIVITY; ARTICLE; DRUG EFFECT; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; MYCOBACTERIUM; MYCOBACTERIUM LUFU; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN;

EID: 33751551193     PISSN: 0091150X     EISSN: 15739031     Source Type: Journal    
DOI: 10.1007/s11094-006-0131-6     Document Type: Article

References (10)

1. J. S. Blanchard, Ann, Rev. Biochem, 65, 215 - 239 (1996).
2. T. Berdsley and V. Mire, Nauki [Russian Edition of Scientific American], No. 1, 78 - 79 (1993).
3. A. G. Tyrkov, Zh. Org. Khim., 36(10), 1580 - 1581 (2000).
4. A. G. Tyrkov, Zh. Org. Khim., 36(5), 788 - 789 (2000).
5. L. Titze and T. Aicher, Preparative Organic Chemistry [Russian Translation], Mir, Moscow (1999), p. 521.
6. J. Kirchner, Thin-Layer Chromatography, Wiley, New York (1978).
7. O. A. Irtuganova and N. G. Urlyapova A. S., in: Current Problems in Leprology [in Russian], Astrakhan (1984), pp. 147 - 150.
8. Manual of Methods for General Bacteriology, F. Gerhardt, et al.(ed.), American Society for Microbiology, Washington (1981).
9. A Practical Guide on Experimental (Preclinical) Investigation of New Pharmaceuticals [in Russian], Remedium, Moscow (2000), pp. 360 - 385.
10. O. N. Elizarova, Determining Threshold Doses of Industrial Poisons upon Peroral Administration [in Russian], Meditsina, Moscow (1971), pp. 207, 240.